Orchid Pharma Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 20, 2025
ORCHPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Orchid Pharma Limited has filed the proceedings of its Annual General Meeting held on September 20, 2025 with the stock exchange. This is a routine regulatory disclosure confirming that the AGM took place as scheduled. The filing typically includes voting results on resolutions such as adoption of financial statements, director appointments, auditor ratification, and any special business. The detailed outcome of the resolutions voted upon is usually enclosed as part of the submission.
This is a standard compliance filing with no direct material impact on shareholders. Investors should review the detailed voting results for any significant decisions on capital, dividends, or board changes.